IB
Intrust Bank’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.49M | Buy |
13,851
+929
| +7% | +$99.8K | 0.13% | 125 |
|
2025
Q1 | $1.3M | Buy |
12,922
+950
| +8% | +$95.8K | 0.13% | 125 |
|
2024
Q4 | $1.07M | Buy |
11,972
+795
| +7% | +$71K | 0.11% | 143 |
|
2024
Q3 | $937K | Buy |
11,177
+301
| +3% | +$25.2K | 0.09% | 159 |
|
2024
Q2 | $838K | Buy |
10,876
+147
| +1% | +$11.3K | 0.09% | 165 |
|
2024
Q1 | $735K | Sell |
10,729
-496
| -4% | -$34K | 0.08% | 196 |
|
2023
Q4 | $649K | Buy |
11,225
+730
| +7% | +$42.2K | 0.08% | 206 |
|
2023
Q3 | $554K | Buy |
10,495
+581
| +6% | +$30.7K | 0.07% | 219 |
|
2023
Q2 | $536K | Sell |
9,914
-45
| -0.5% | -$2.43K | 0.07% | 232 |
|
2023
Q1 | $498K | Buy |
9,959
+758
| +8% | +$37.9K | 0.06% | 238 |
|
2022
Q4 | $426K | Buy |
9,201
+684
| +8% | +$31.6K | 0.06% | 246 |
|
2022
Q3 | $330K | Buy |
8,517
+2,382
| +39% | +$92.3K | 0.05% | 271 |
|
2022
Q2 | $229K | Sell |
6,135
-120
| -2% | -$4.48K | 0.03% | 342 |
|
2022
Q1 | $277K | Buy |
6,255
+664
| +12% | +$29.4K | 0.04% | 332 |
|
2021
Q4 | $238K | Buy |
5,591
+610
| +12% | +$26K | 0.03% | 369 |
|
2021
Q3 | $216K | Sell |
4,981
-116
| -2% | -$5.03K | 0.03% | 361 |
|
2021
Q2 | $218K | Sell |
5,097
-1,231
| -19% | -$52.7K | 0.03% | 352 |
|
2021
Q1 | $244K | Sell |
6,328
-826
| -12% | -$31.9K | 0.04% | 336 |
|
2020
Q4 | $257K | Sell |
7,154
-142
| -2% | -$5.1K | 0.04% | 313 |
|
2020
Q3 | $279K | Buy |
7,296
+455
| +7% | +$17.4K | 0.05% | 269 |
|
2020
Q2 | $240K | Sell |
6,841
-69
| -1% | -$2.42K | 0.05% | 288 |
|
2020
Q1 | $225K | Buy |
+6,910
| New | +$225K | 0.06% | 276 |
|